Cargando…

Promising Nanomedicines of Shikonin for Cancer Therapy

Malignant tumor, the leading cause of death worldwide, poses a serious threat to human health. For decades, natural product has been proven to be an essential source for novel anticancer drug discovery. Shikonin (SHK), a natural molecule separated from the root of Lithospermum erythrorhizon, shows g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Chunmei, Li, Qiuxia, Sun, Qiang, Yang, Lu, Liu, Xing, Zhao, Yuxin, Shi, Mingyi, Li, Xiaofang, Luo, Kaipei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013574/ https://www.ncbi.nlm.nih.gov/pubmed/36926681 http://dx.doi.org/10.2147/IJN.S401570

Ejemplares similares

Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination
por: Feng, Wenjie, et al.
Publicado: (2023)

Is nanomedicine still promising?
por: Peiris, Pubudu M., et al.
Publicado: (2011)

Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
por: Xu, Yiming, et al.
Publicado: (2023)

Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
por: Luo, Meihua, et al.
Publicado: (2022)

Nanomedicine: promises and challenges for the future of public health
por: Pautler, Michelle, et al.
Publicado: (2010)

Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
por: Li, Wenjuan, et al.
Publicado: (2014)

Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2014)

Mitochondria-Targeted Nanomedicine for Enhanced Efficacy of Cancer Therapy
por: Gao, Yan, et al.
Publicado: (2021)

Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation
por: Li, Wenjuan, et al.
Publicado: (2015)

Multifunctional Cargo-Free Nanomedicine for Cancer Therapy
por: Wang, Ying, et al.
Publicado: (2018)

An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells
por: Yang, Jen-Tsung, et al.
Publicado: (2014)

Shikonin inhibits cancer cell cycling by targeting Cdc25s
por: Zhang, Shoude, et al.
Publicado: (2019)

Protein-Caged Nanoparticles: A Promising Nanomedicine Against Cancer
por: Mohanty, Ayeskanta, et al.
Publicado: (2023)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Nanomedicine in cancer therapy
por: Fan, Dahua, et al.
Publicado: (2023)

Polycaprolactone Nanoparticles as Promising Candidates for Nanocarriers in Novel Nanomedicines
por: Łukasiewicz, Sylwia, et al.
Publicado: (2021)

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
por: Khan, Nazeer Hussain, et al.
Publicado: (2021)

Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential
por: Vichare, Riddhi, et al.
Publicado: (2022)

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy
por: Li, Yang-Ling, et al.
Publicado: (2018)

Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1
por: Huang, Chuanjiang, et al.
Publicado: (2013)

Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways
por: JING, HUILING, et al.
Publicado: (2016)

Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine
por: Wei, Wumei, et al.
Publicado: (2021)

Correction: Shikonin inhibits cancer cell cycling by targeting Cdc25s
por: Zhang, Shoude, et al.
Publicado: (2023)

Stimuli-activatable nanomedicine meets cancer theranostics
por: Li, Haonan, et al.
Publicado: (2023)

Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems
por: Juliana, Fidiniaina Rina, et al.
Publicado: (2019)

The anti-leukemia activity and mechanisms of shikonin: a mini review
por: Dong, Han, et al.
Publicado: (2023)

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
por: Navarro-Ocón, Alba, et al.
Publicado: (2022)

Effect of Shikonin Against Candida albicans Biofilms
por: Yan, Yu, et al.
Publicado: (2019)

Magnetic hydroxyapatite: a promising multifunctional platform for nanomedicine application
por: Mondal, Sudip, et al.
Publicado: (2017)

Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis
por: Negi, Poonam, et al.
Publicado: (2019)

The application of nanomedicine in clinical settings
por: Zhao, Qingsong, et al.
Publicado: (2023)

Shikonin Inhibits Fin Regeneration in Zebrafish Larvae
por: Cao, Zigang, et al.
Publicado: (2022)

A novel biomimetic nanomedicine system with anti-inflammatory and anti-osteoporosis effects improves the therapy efficacy of steroid-resistant nephrotic syndrome
por: Li, Jian, et al.
Publicado: (2021)

Nanomedicine for Combination Therapy of Cancer
por: He, Chunbai, et al.
Publicado: (2015)

Immunomodulating Nanomedicine for Cancer Therapy
por: Liu, Zhigang, et al.
Publicado: (2018)

Epigenetics in cancer therapy and nanomedicine
por: Roberti, Annalisa, et al.
Publicado: (2019)

Nanomedicine in Cancer Targeting and Therapy
por: Palamà, Ilaria Elena, et al.
Publicado: (2022)

Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle
por: Su, Yonghua, et al.
Publicado: (2017)

Evaluation of radical scavenging properties of shikonin
por: Yoshida, Lucia S., et al.
Publicado: (2014)

Shikonin induced Apoptosis Mediated by Endoplasmic Reticulum Stress in Colorectal Cancer Cells
por: Qi, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tdt498crhf2blmhk2ts61orkpi